ADVISORY COMMITTEE RECOMMENDS Rx CHANGES
Senate Bill 437, passed by the 2012 Legislature to curb abuse of controlled substances, created an Advisory Committee under the Board of Pharmacy. Consisting of four medical doctors, an osteopathic physician, a dentist, a pharmacist and an expert in drug diversion, the Committee is to develop, implement and recommend parameters to be used to identify abnormal or unusual usage patterns of controlled substances for patients. The pharmacist appointed to the Committee is Patty Johnston, RPh, of Colony Drug in Beckley.
Below are current recommendations of the Committee and the Board of Pharmacy's actions on those recommendations.
1. The Committee recommended the Legislature make tramadol a Schedule V controlled substance. The Board of Pharmacy approved this recommendation.
2. It recommended that if tramadol is not made a controlled substance, then it should be required to be reported to the Controlled Substance Monitoring Program as a "drug of concern." The Board of Pharmacy approved this recommendation.
3. It recommended the Legislature require a prescription for pseudoephedrine products. The Board of Pharmacy approved this recommendation.
4. In an action separate from the Advisory Committee, the Board of Pharmacy voted to request the Legislature to limit sales of pseudoephedrine to no more than one box of 3.6 grams or less per month and lower the annual limit to 24 grams should the Legislature not require prescriptions for the products.
5. The Advisory Committee recommended the CSMP be expanded to track dispensing of Schedule V drugs (currently IIs, IIIs and IVs require dispensing reporting). The Board approved this recommendation.
6. The Committee recommended setting a parameter for the Board of Pharmacy to search for outlier-patients or "doctor-shoppers" to identify potential for drug diversion and abuse and run reports on any patient seeking six (6) or more prescriptions at four (4) or more pharmacies in a 12-month period of time. It also recommended the Board notify practitioners who wrote the prescriptions and appropriate law enforcement agencies of the "doctor-shoppers." The Board of Pharmacy delayed action on this recommendation until it can determine if the CSMP is currently capable of running this type of report.
7. The Advisory Committee recommended the Board implement a rule clarifying that a prescriber or dispenser may run a patient profile report prior to accepting that person as a patient once that patient has requested to come under the practitioner's care (such as a new patient or referral). The Board approved this recommendation.
8. The Committee recommended the Board implement a rule clarifying that it is permissible for a prescriber or dispenser to access the prescription drug profile of the mother for the purpose of treating a newborn child or child being breastfed. The Board approved this recommendation.
9. The Committee recommended the Legislature clarify that the person whose identity must be verified with a government-issued photo ID is the person picking up a prescription at the pharmacy, whether on their own behalf or on behalf of another person. This will make it clear pharmacies are to request the ID of the person picking up the prescription. The Board approved this recommendation.
10. The Committee recommended the Legislature amend the requirements for law enforcement training to include training approved by the Board of Pharmacy and delete the current required training is with the DEA. The Board of Pharmacy approved this.
The Advisory Committee will continue study of additional recommendations.
CONVENTION DRAWS GREAT ATTENDANCE
Over 180 pharmacists and students attended WVPA's 106th Annual Convention at Stonewall Resort, August 24 and 25. "We are certainly pleased with the turnout", said President Jason Turner, Moundsville Pharmacy owner, who presided over the meeting.
"Attendees were updated on the Affordable Care Act and to implement medication therapy management in their practices, among the outstanding CE programs held", added Turner. Up to 14 hours of CE were available to pharmacists and seven hours to pharmacy technicians over the two days.
Officers elected for 2013-14 are: Jason Turner, President; Betsy Elswick, Past President; Krista Capehart, President Elect; Craig Kimble, Treasurer; Patty Johnston, Director at Large; Katie Kacmarik, Director at Large; Emily Judy, Community Pharmacy Director; C. K. Babcock, Employed Pharmacists Director; Jeremy Prunty, Institutional Pharmacy Director; Dean Kevin Yingling, Marshall University School of Pharmacy; Dean Michelle Easton, University of Charleston School of Pharmacy; and Dean Pat Chase, WVU School of Pharmacy. A student from each of the three Schools of Pharmacy will also serve on Board of Directors.
Vendors supporting the Convention were American Pharmacy Services Corporation, Astra Zeneca, Bayer HealthCare, Cardinal Health, Electronic Billing Services, Inc.,1-Runner Diabetic Shoes, Merck & Co., Miami Luken, Mylan Pharmaceutical, Inc., National Association of Chain Drug Stores, Novo Nordisk, The Center for Rural Health Development, and the State's three pharmacy schools, Marshall University, WVU and University of Charleston.
C. K. Babcock, was presented the Excellence In Innovation Award, by President Turner during the Installation and Awards Dinner. President Turner presented the Distinguished Pharmacist Award to Cassandra Ford. Past President Arlie Winters, Jr., received the coveted Bowl of Hygeia Award. Executive Director Richard Stevens presented Jason Turner with the Dr. James H. Beale Award, the highest honor the Association can bestow a member.
The 107th Annual Convention will be held August 23 and 24, 2014, at Stonewall. The Resort offers several amenities that can be enjoyed by pharmacists and their families.
SCHOOLS OF PHARMACY REPORT